The Global CAR-T Cell Therapy Market was valued at US$ 2.15 billion in 2024 and is projected to reach US$ 15.8 billion by 2033, registering a CAGR of 23.1% during the forecast period 2025–2033. The market is expanding rapidly due to rising demand for personalized cancer treatments and innovations in immunotherapy. Advances in genetic engineering, cell modification technologies, and...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek